Lisata Therapeutics(LSTA) - 2022 Q4 - Annual Report

FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 22-2343568 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 110 Allen Road, 2nd Floor, Basking Ridge, New Jersey 07920 (Address of pri ...